Innovent Biologics Inc
HKEX:1801

Watchlist Manager
Innovent Biologics Inc Logo
Innovent Biologics Inc
HKEX:1801
Watchlist
Price: 50.25 HKD 0.8% Market Closed
Market Cap: 82.3B HKD

Intrinsic Value

The intrinsic value of one Innovent Biologics Inc stock under the Base Case scenario is 46.9 HKD. Compared to the current market price of 50.25 HKD, Innovent Biologics Inc is Overvalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
46.9 HKD
Overvaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Innovent Biologics Inc

Innovent Biologics Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Innovent Biologics Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Innovent Biologics Inc
HKEX:1801
CN
Biotechnology
Market Cap
82.3B HKD
IPO
Oct 31, 2018
CN
Biotechnology
Market Cap
82.3B HKD
IPO
Oct 31, 2018
Price
HK$false
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Innovent Biologics Inc?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Innovent Biologics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Innovent Biologics Inc

Current Assets 10.3B
Cash & Short-Term Investments 7.9B
Receivables 1.2B
Other Current Assets 1.2B
Non-Current Assets 11.3B
Long-Term Investments 3.6B
PP&E 5.8B
Intangibles 1.3B
Other Non-Current Assets 627.4m
Efficiency

Free Cash Flow Analysis
Innovent Biologics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Innovent Biologics Inc

Revenue
9.4B CNY
Cost of Revenue
-1.5B CNY
Gross Profit
7.9B CNY
Operating Expenses
-8B CNY
Operating Income
-89.7m CNY
Other Expenses
-4.9m CNY
Net Income
-94.6m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Innovent Biologics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROE is Increasing
ROIC is Increasing
38/100
Profitability
Score

Innovent Biologics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Innovent Biologics Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Negative Net Debt
Long-Term Solvency
65/100
Solvency
Score

Innovent Biologics Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Innovent Biologics Inc

Wall Street analysts forecast Innovent Biologics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Innovent Biologics Inc is 56.51 HKD with a low forecast of 35.35 HKD and a high forecast of 70.35 HKD.

Lowest
Price Target
35.35 HKD
30% Downside
Average
Price Target
56.51 HKD
12% Upside
Highest
Price Target
70.35 HKD
40% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Innovent Biologics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Innovent Biologics Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

News

Other Videos
What is the Intrinsic Value of one Innovent Biologics Inc stock?

The intrinsic value of one Innovent Biologics Inc stock under the Base Case scenario is 46.9 HKD.

Is Innovent Biologics Inc stock undervalued or overvalued?

Compared to the current market price of 50.25 HKD, Innovent Biologics Inc is Overvalued by 7%.

Back to Top